RetinalGenix Technologies Inc.
General ticker "RTGN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $60.3M (TTM average)
RetinalGenix Technologies Inc. does not follow the US Stock Market performance with the rate: -2.4%.
Estimated limits based on current volatility of 0.1%: low 3.19$, high 3.20$
Factors to consider:
- Total employees count: 0 as of 2023
- Top business risk factors: Insufficient funding, Dependence on pricing, Product liability, Market competition, Product quality issues
Short-term RTGN quotes
Long-term RTGN plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $1.88MM | $2.09MM | $4.32MM |
| Operating Income | $-1.88MM | $-2.09MM | $-4.32MM |
| Non-Operating Income | $-2.04MM | $-0.00MM | $-0.00MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $0.81MM | $0.52MM | $0.37MM |
| Income(Loss) | $-3.91MM | $-2.09MM | $-4.32MM |
| Profit(Loss)* | $-3.91MM | $-2.09MM | $-4.32MM |
| Stockholders Equity | $-1.07MM | $-1.41MM | $-1.46MM |
| Assets | $0.00MM | $0.00MM | $0.01MM |
| Operating Cash Flow | $-0.20MM | $-0.35MM | $-0.74MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.19MM | $0.35MM | $0.75MM |
| Earnings Per Share** | $-0.25 | $-0.12 | $-0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.